Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Apr;32(1):180-7.
doi: 10.1128/iai.32.1.180-187.1981.

Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1

Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1

P S Morahan et al. Infect Immun. 1981 Apr.

Abstract

The kinetics of appearance of five humoral antibody responses (micro-neutralization assay [NT], complement fixation [CF], enzyme-linked immunosorbent assay [ELISA], radioimmunoassay [RIA], antibody-dependent cell-mediated cytotoxicity [ADCC]), were compared during labial infection of BALB/c mice with herpes simplex virus type 1 strain Patton. The ELISA/RIA antibody responses were present in most mice by day 5 after infection, at the beginning of the herpetic lip lesions; antibody effective in ADCC showed identical early kinetics. In contrast, NT/CF antibodies were not detected in most mice until day 10, at the time of resolution of the herpetic lip lesions. The humoral immune responses persisted for at least 6 months after infection. The NT and CF responses were closely correlated in time of appearance and titers (r = 0.9), as were the ELISA and RIA responses (r = 0.99). However, there was little correlation between NT/CF and ELISA/RIA responses (r = 0.02). The kinetics of the delayed type hypersensitivity response showed similar kinetics of appearance to the ELISA/RIA/ADCC humoral responses, and peaked similarly, but waned gradually over 2 months. The importance of antibody in protection against labial herpes simplex virus type 1 infection was demonstrated by the ability of passively transferred convalescent serum (that produced a minimum NT titer of 10 in recipient mice) to protect against development of herpetic lesions and death.

PubMed Disclaimer

References

    1. J Infect Dis. 1973 Jun;127(6):632-8 - PubMed
    1. J Exp Med. 1974 Sep 1;140(3):764-78 - PubMed
    1. J Immunol. 1974 Dec;113(6):1685-93 - PubMed
    1. Science. 1975 May 30;188(4191):938-40 - PubMed
    1. Infect Immun. 1975 Jul;12(1):166-72 - PubMed

Publication types

Substances